News

Fda approves Zevaskyn for rare, genetic skin disorder
The U.S. Food and Drug Administration has approved Abeona Therapeutics' Zevaskyn (prademagene zamikeracel) for patients with ...
Medscape19h
FDA Approves First One-Time Topical Treatment for Recessive Dystrophic Epidermolysis Bullosa Wounds
In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...
Fierce Biotech20h
Roche receives FDA breakthrough label for AI-powered lung cancer companion diagnostic test
Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...
The American Journal of Managed Care21h
FDA Approves Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa
Prademagene zamikeracel (Zevaskyn) is the first and only cell-based gene therapy for wound treatment in patients with ...
WebMD4d
What Is Stem Cell Donation?
After you mail it back, your cheek cells will be tested at a lab to learn your HLA type. Then, you’ll be added to the registry and contacted if someone needs your stem cells. That could happen ...
Scientific Research Publishing5d
Evaluation of the Hair Growth-Promoting Effects of Combined Treatment with Hair Growth Stimulants ()
Suzuki, R. (2025) Evaluation of the Hair Growth-Promoting Effects of Combined Treatment with Hair Growth Stimulants. Health, ...
BuzzFeed on MSN5d
~Spring~ Into Radiance With These 26 Korean Skincare Products For That Glass Skin Glow
"Prepare for your face to look like it was kissed by angels (and snails)." — a reviewer after experiencing this much-hyped ...